Katie Bernardoni, MD | |
49650 Cherry Hill Rd Ste 220, Canton, MI 48187-4860 | |
(734) 398-7888 | |
Not Available |
Full Name | Katie Bernardoni |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 16 Years |
Location | 49650 Cherry Hill Rd Ste 220, Canton, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457514465 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 4301092696 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Iha Health Services Corporation | 2466351440 | 911 |
News Archive
New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL).
In a new study it was seen that men diagnosed with coronary heart disease with low testosterone were almost twice as likely to die over a seven year period. The team led by Prof Kevin Channer a cardiologist of the Royal Hallamshire Hospital in Sheffield looked at 930 men for the study. This study is in contrast to the popular belief that testosterone increases heart disease risk. The study was published in the journal Online First Heart.
Researchers at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, a national leader in the early adoption and use of advanced treatments for cancer patients, will soon become the first in the world to test an innovative radiotherapy system from ViewRay, Inc. The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of medical imaging and radiotherapy delivery.
As organizations that are committed to promoting accurate and appropriate evidence-based policies and practices to improve the quality of health care services in the United States, we are disappointed that the appointment today of 19 members to the Board of Governors for the new Patient-Centered Outcomes Research Institute (PCORI) includes only one Board member that directly represents patients.
VisionShare, one of the nation's largest and most secure health information exchanges for administrative transactions, today announced plans to expand support for the exchange of clinical transactions on its platform and making connectivity to the Nationwide Health Information Network (NHIN) and state and community-based Health Information Exchanges (HIEs) available to its customers.
› Verified 2 days ago
Entity Name | Iha Health Services Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355 |
News Archive
New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL).
In a new study it was seen that men diagnosed with coronary heart disease with low testosterone were almost twice as likely to die over a seven year period. The team led by Prof Kevin Channer a cardiologist of the Royal Hallamshire Hospital in Sheffield looked at 930 men for the study. This study is in contrast to the popular belief that testosterone increases heart disease risk. The study was published in the journal Online First Heart.
Researchers at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, a national leader in the early adoption and use of advanced treatments for cancer patients, will soon become the first in the world to test an innovative radiotherapy system from ViewRay, Inc. The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of medical imaging and radiotherapy delivery.
As organizations that are committed to promoting accurate and appropriate evidence-based policies and practices to improve the quality of health care services in the United States, we are disappointed that the appointment today of 19 members to the Board of Governors for the new Patient-Centered Outcomes Research Institute (PCORI) includes only one Board member that directly represents patients.
VisionShare, one of the nation's largest and most secure health information exchanges for administrative transactions, today announced plans to expand support for the exchange of clinical transactions on its platform and making connectivity to the Nationwide Health Information Network (NHIN) and state and community-based Health Information Exchanges (HIEs) available to its customers.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Katie Bernardoni, MD 49650 Cherry Hill Rd Ste 220, Canton, MI 48187-4860 Ph: () - | Katie Bernardoni, MD 49650 Cherry Hill Rd Ste 220, Canton, MI 48187-4860 Ph: (734) 398-7888 |
News Archive
New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL).
In a new study it was seen that men diagnosed with coronary heart disease with low testosterone were almost twice as likely to die over a seven year period. The team led by Prof Kevin Channer a cardiologist of the Royal Hallamshire Hospital in Sheffield looked at 930 men for the study. This study is in contrast to the popular belief that testosterone increases heart disease risk. The study was published in the journal Online First Heart.
Researchers at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, a national leader in the early adoption and use of advanced treatments for cancer patients, will soon become the first in the world to test an innovative radiotherapy system from ViewRay, Inc. The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of medical imaging and radiotherapy delivery.
As organizations that are committed to promoting accurate and appropriate evidence-based policies and practices to improve the quality of health care services in the United States, we are disappointed that the appointment today of 19 members to the Board of Governors for the new Patient-Centered Outcomes Research Institute (PCORI) includes only one Board member that directly represents patients.
VisionShare, one of the nation's largest and most secure health information exchanges for administrative transactions, today announced plans to expand support for the exchange of clinical transactions on its platform and making connectivity to the Nationwide Health Information Network (NHIN) and state and community-based Health Information Exchanges (HIEs) available to its customers.
› Verified 2 days ago
Dr. Cristina Lete, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 49650 Cherry Hill Rd, Suite 220, Canton, MI 48187 Phone: 734-398-7888 Fax: 734-398-7885 | |
Alice May Chi, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1051 N Canton Center Drive, Canton, MI 48187 Phone: 734-844-5400 | |
Charles Cash Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7300 N Canton Center Rd, Canton, MI 48187 Phone: 734-454-8001 | |
Dr. Seamus O'broin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1051 North Canton Center Rd, Canton, MI 48187 Phone: 734-844-5400 | |
Dr. Jyothi R. Nichanametla, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 42287 Cherry Hill Rd, Suite D, Canton, MI 48188 Phone: 734-981-2800 Fax: 734-981-2800 | |
Roger Douglas Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1051 N Canton Center Rd, Canton, MI 48187 Phone: 348-445-2897 | |
Lynn Baca, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 49650 Cherry Hill Rd Ste 220, Canton, MI 48187 Phone: 734-398-7888 Fax: 734-398-7885 |